Pharmaresearch Bio Co (XKRX:217950) Other Operating Expense : ₩2,466 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Other Operating Expense?

Pharmaresearch Bio Co's Other Operating Expense for the six months ended in Dec. 2024 was ₩2,466 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩2,466 Mil.

Pharmaresearch Bio Co's quarterly Other Operating Expense increased from Dec. 2022 (₩1,755 Mil) to Dec. 2023 (₩1,866 Mil) and increased from Dec. 2023 (₩1,866 Mil) to Dec. 2024 (₩2,466 Mil).

Pharmaresearch Bio Co's annual Other Operating Expense increased from Dec. 2022 (₩1,755 Mil) to Dec. 2023 (₩1,866 Mil) and increased from Dec. 2023 (₩1,866 Mil) to Dec. 2024 (₩2,466 Mil).

Pharmaresearch Bio Co Other Operating Expense Historical Data

The historical data trend for Pharmaresearch Bio Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Other Operating Expense Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

418.17

672.35

1,755.18

1,865.55

2,465.51

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Other Operating Expense	Get a 7-Day Free Trial			418.17	672.35	1,755.18	1,865.55	2,465.51

Pharmaresearch Bio Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩2,466 Mil.

Pharmaresearch Bio Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines